The Valley Desk

Clinical trial reportEuropean journal of cancer (Oxford, England : 1990)Published

OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
European journal of cancer (Oxford, England : 1990)
Published
Subject terms
Humans; Breast Neoplasms; Piperazines; Phthalazines; Follow-Up Studies; Germ-Line Mutation; Genes, BRCA1; Genes, BRCA2; Physicians; Female; Erb-b2 Receptor Tyrosine Kinases; Breast cancer
PubMed ID
36893711
PubMed Central ID
PMC10585240
Added to directory
Source checked

Report a correction or request removal